Could a Mail-In HPV test replace the pap smear?

NCT ID NCT07575217

ENROLLING_BY_INVITATION Diagnosis Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times

Summary

This study tests whether mailing HPV self-sampling kits to people who are overdue for cervical cancer screening makes it easier for them to get tested. Researchers will enroll 200 women, transgender men, and nonbinary individuals aged 30-75 in New Jersey. Participants can choose to use the mailed kit or go to a clinic for a standard Pap smear. The goal is to see if this approach improves screening rates and is acceptable to users.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV self-sampling kit
What this could lead to: If successful, this could make cervical cancer screening more accessible and convenient for people who miss regular checkups.
What could go wrong: This is a small, early-stage study (200 participants) focused on feasibility, not on detecting cancer directly. The self-sampling method may not be as accurate as clinic-based tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING

Contacts and locations

Locations

Rutgers New Jersey Medical School

Newark, New Jersey, 07103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.